SNST Stock Overview
Aphex BioCleanse Systems, Inc. desarrolla soluciones desinfectantes sin alcohol.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Sunset Capital Assets, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0072 |
| 52 Week High | US$0.04 |
| 52 Week Low | US$0.002 |
| Beta | 0 |
| 1 Month Change | 19.50% |
| 3 Month Change | 17.54% |
| 1 Year Change | -82.03% |
| 3 Year Change | -99.54% |
| 5 Year Change | n/a |
| Change since IPO | -99.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| SNST | US Household Products | US Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -0.8% |
| 1Y | -82.0% | 4.9% | 25.9% |
Rentabilidad frente al sector: SNST obtuvo unos resultados inferiores a los del sector US Household Products , que el año pasado arrojó un rendimiento del 17.1%.
Rentabilidad vs. Mercado: SNST obtuvo unos resultados inferiores a los del mercado US, que fue del 31.8% el año pasado.
Price Volatility
| SNST volatility | |
|---|---|
| SNST Average Weekly Movement | n/a |
| Household Products Industry Average Movement | 2.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: SNSTha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de SNST en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | n/a | https://www.aphexus.com |
Aphex BioCleanse Systems, Inc. desarrolla soluciones desinfectantes sin alcohol. Sus productos incluyen desinfectantes, desinfectantes de superficies, lavado de heridas y soluciones para el tratamiento del ganado. La empresa se constituyó en 2010 y tiene su sede en Rochester, Nueva York.
Sunset Capital Assets, Inc. Fundamentals Summary
| SNST fundamental statistics | |
|---|---|
| Market cap | US$1.91m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SNST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNST income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SNST perform over the long term?
See historical performance and comparison